Surgeons report progress against dangerous hospital infection
There has never been any medical treatment available to prevent Clostridium difficile. But in findings presented Thursday at the 2012 Annual American College of Surgeons Clinical Congress in Chicago, surgeons report success using a medicine called intestinal alkaline phosphate (IAP) to prevent C. difficile infections in tests on mice. "According to the CDC, C. difficile is linked to about 14,000 U.S. deaths every year," says Dr. Richard Hodin, a surgeon at Massachusetts General Hospital and the principal investigator of the study. In the study, Hodin and colleagues found that giving IAP to mice on antibiotics resulted in a 10-fold decrease in C. difficile bacteria in their stool, as well as a 10-fold decrease in in inflammatory marker called IL-1.
- CMS Sets 2014 Pay Rates for Hospital Outpatient and Physician Services
- The 5 Biggest Healthcare Finance Trouble Spots
- FDA hopes hospitals will switch to newly regulated pharmacies
- Nonprofit Hospital Outlook 'Negative' in 2014
- Not-for-Profit Hospitals Find Opportunity Amid Uncertainty
- Are ACOs Really Different from HMOs?
- The Most Polarizing Topics in Healthcare IT
- How CPOE Will Make Healthcare Smarter
- Rise of the Chief Strategy Officer
- Google Glass Passes IRB Muster, Assists in Cardiothoracic Surgeries